CANDACE JONES-MARTIN: Open Payments
NPI 1598370694 · GEORGETOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 26 payments from 9 companies in 2025. Trend: 2023 $895 · 2024 $517 · 2025 $656
Food & beverage: $611Education: $45
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $156 |
| Paratek Pharmaceuticals, Inc. | 4 | $104 |
| ViiV Healthcare Company | 4 | $91 |
| Aimmune Therapeutics, Inc. | 4 | $75 |
| Astellas Pharma US Inc | 2 | $68 |
| Gilead Sciences, Inc. | 2 | $46 |
| ABBVIE INC. | 2 | $42 |
| Antares Pharma, Inc. | 2 | $38 |
| Insmed, Inc. | 2 | $36 |
Products named: ZERBAXA, NUZYRA, APRETUDE, VOWST, XYOSTED, Arikayce, MAVYRET, Cresemba.
Industry payments across KY — which companies pay providers there.
